384 related articles for article (PubMed ID: 17134770)
41. Clinical benefits of trimetazidine in patients with recurrent angina.
Szwed H
Coron Artery Dis; 2004 May; 15 Suppl 1():S17-21. PubMed ID: 15179124
[TBL] [Abstract][Full Text] [Related]
42. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
43. Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]).
Schoenenberger AW; Kobza R; Jamshidi P; Zuber M; Abbate A; Stuck AE; Pfisterer M; Erne P
Am J Cardiol; 2009 Jul; 104(2):158-63. PubMed ID: 19576339
[TBL] [Abstract][Full Text] [Related]
44. Long-term effects of spinal cord stimulation on myocardial ischemia and heart rate variability: results of a 48-hour ambulatory electrocardiographic monitoring.
Di Pede F; Zuin G; Giada F; Pinato G; Turiano G; Bevilacqua M; Cazzin R; Raviele A
Ital Heart J; 2001 Sep; 2(9):690-5. PubMed ID: 11666098
[TBL] [Abstract][Full Text] [Related]
45. Randomized clinical trial France DMLA2: effect of trimetazidine on exudative and nonexudative age-relatedmacular degeneration.
Cohen SY; Bourgeois H; Corbe C; Chaine G; Espinasse-Berrod MA; Garcia-Sanchez J; Gaudric A; Hullo A; Leys A; Soubrane G; Sahel J
Retina; 2012 Apr; 32(4):834-43. PubMed ID: 21822162
[TBL] [Abstract][Full Text] [Related]
46. Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy.
Wenmeng W; Qizhu T
Med Hypotheses; 2011 Feb; 76(2):181-3. PubMed ID: 20932648
[TBL] [Abstract][Full Text] [Related]
47. Effects of trimetazidine in nonischemic heart failure: a randomized study.
Winter JL; Castro PF; Quintana JC; Altamirano R; Enriquez A; Verdejo HE; Jalil JE; Mellado R; Concepción R; Sepúlveda P; Rossel V; Sepúlveda L; Chiong M; García L; Lavandero S
J Card Fail; 2014 Mar; 20(3):149-54. PubMed ID: 24412523
[TBL] [Abstract][Full Text] [Related]
48. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
[TBL] [Abstract][Full Text] [Related]
49. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
Kolomoets NM; Baksheev VI; Uvaĭsova KU
Klin Med (Mosk); 2008; 86(6):38-43. PubMed ID: 18720710
[TBL] [Abstract][Full Text] [Related]
50. Metabolic agents in the management of diabetic coronary patients: a new era.
Celik T; Kursaklioglu H; Iyisoy A; Jata B
Int J Cardiol; 2008 Jun; 127(1):133-4. PubMed ID: 17561287
[TBL] [Abstract][Full Text] [Related]
51. [Prevalence of silent myocardial ischemia in non-insulin dependent diabetes].
Tamez-Pérez HE; Oliveros-Rodríguez A; Gómez-de-Ossio MD
Rev Invest Clin; 1996; 48(5):351-4. PubMed ID: 9005511
[TBL] [Abstract][Full Text] [Related]
52. [The importance of ambulatory ECG monitoring for determining the prognosis of patients with stable stenocardia].
Shipilova T; Pshenichnikov I; Laane P
Ter Arkh; 1997; 69(4):31-4. PubMed ID: 9213953
[TBL] [Abstract][Full Text] [Related]
53. Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients: is it appropriate and cost-effective?
Beller GA
J Am Coll Cardiol; 2007 May; 49(19):1918-23. PubMed ID: 17498575
[TBL] [Abstract][Full Text] [Related]
54. Trimetazidine-induced enhancement of myocardial recovery during reperfusion: a comparative study in diabetic and non-diabetic rat hearts.
Ikizler M; Erkasap N; Dernek S; Batmaz B; Kural T; Kaygisiz Z
Arch Med Res; 2006 Aug; 37(6):700-8. PubMed ID: 16824928
[TBL] [Abstract][Full Text] [Related]
55. [Asymptomatic myocardial ischemia before and after surgical revascularization in patients with multivessel occlusive coronary disease].
Kovacevic DV; Topalov V; Kovacević D; Radovanović N
Med Pregl; 1998; 51(1-2):73-5. PubMed ID: 9531779
[TBL] [Abstract][Full Text] [Related]
56. Advantages of myocardial revascularization after admission for critical limb ischemia in diabetic patients with coronary artery disease: data of a cohort of 564 consecutive patients.
Faglia E; Clerici G; Caminiti M; Quarantiello A; Curci V; Morabito A
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1030-6. PubMed ID: 18799966
[TBL] [Abstract][Full Text] [Related]
57. [Frequency of silent ischemic heart disease in patients with diabetes mellitus].
Negrusz-Kawecka M; Moszczyńska-Stulin J; Zytkiewicz-Jaruga D; Salomon P
Pol Merkur Lekarski; 1997 Aug; 3(14):53-6. PubMed ID: 9480174
[TBL] [Abstract][Full Text] [Related]
58. [Silent myocardial ischemia: its increase with aging].
Azevedo Ade C; de Souza PJ; Bueno MS; Loyola LH; Albuquerque SS; Sekeff JA
Arq Bras Cardiol; 1991 Oct; 57(4):281-5. PubMed ID: 1824523
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
Ruzyllo W; Szwed H; Sadowski Z; Elikowski W; Grzelak-Szafranska H; Orszulak W; Szymczak K; Winter M
Curr Med Res Opin; 2004 Sep; 20(9):1447-54. PubMed ID: 15383193
[TBL] [Abstract][Full Text] [Related]
60. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
Grabczewska Z; Białoszyński T; Szymański P; Sukiennik A; Swiatkiewicz I; Koziński M; Kochman W; Grześk G; Kubica J
Cardiol J; 2008; 15(4):344-50. PubMed ID: 18698543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
